Medicine & Life Sciences
anacetrapib
10%
Apolipoprotein A-I
45%
Apolipoprotein A-II
26%
apolipoprotein A-IV
9%
Apolipoprotein B-100
26%
Apolipoprotein C-II
19%
Apolipoprotein C-III
13%
Apolipoproteins
49%
Apolipoproteins A
10%
Apolipoproteins B
35%
Apolipoproteins C
21%
Apolipoproteins E
15%
Apoproteins
33%
Atherosclerosis
30%
Cardiovascular Diseases
16%
Cholesterol
64%
Cholesterol Esters
16%
Coronary Artery Disease
40%
Coronary Disease
24%
Diet
17%
Dimyristoylphosphatidylcholine
24%
Dyslipidemias
16%
Fluvastatin
12%
HDL Cholesterol
41%
HDL Lipoproteins
59%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
47%
Hypercholesterolemia
20%
Hyperlipidemias
16%
LDL Cholesterol
49%
LDL Lipoproteins
55%
LDL Receptors
14%
lipid-associating peptides
10%
Lipids
82%
Lipoprotein Lipase
18%
Lipoproteins
69%
Liver
11%
Lovastatin
14%
Meta-Analysis
14%
opacity factor
15%
oxidized low density lipoprotein
22%
Peptides
17%
Phosphatidylcholine-Sterol O-Acyltransferase
12%
Phosphatidylcholines
21%
Phospholipids
27%
Placebos
11%
Primary Prevention
15%
Proteins
19%
Therapeutics
16%
Triglycerides
30%
VLDL Lipoproteins
29%
Chemistry
3-Hydroxy-3-Methylglutaryl-CoA
6%
Apolipoprotein
100%
Apoprotein
24%
Cholesterol
27%
Cholesteryl Ester
6%
Complementary DNA
5%
Fat
5%
High-Density Lipoprotein
45%
High-Density Lipoprotein Cholesterol
5%
Lecithin
9%
Lipid
26%
Lipoprotein
55%
Lipoprotein Structure
5%
Low-Density Lipoprotein
37%
Opacity
5%
Peptide
15%
Pharmacological Metabolism
9%
Phosphatidylcholine
16%
Phospholipid
17%
Plasma
38%
Protein
16%
Triglyceride
7%
Ultracentrifugation
6%
Very-Low-Density Lipoprotein
22%